Unicycive Therapeutics (UNCY US)

Unicycive Therapeutics, Inc. operates as a biotechnology company. The Company focuses on development of two novel therapies for treatment of hyperphosphatemia in patients with chronic kidney disease and acute kidney injury. Unicycive Therapeutics serves customers in the United States.